By the use of polyacrylamide-gel electrophoresis, uridine kinase from foetal rat liver was separated into four types designated I, II, III and IV in decreasing order of mobility towards the anode. The most anodic (type I) was found only in rapidly growing tissues, such as foetal liver and brain, postnatal spleen and tumour cells. In adult tissues, types II, III and IV were found in the kidney, and types III and IV in the spleen and the liver, whereas type IV was the sole form of uridine kinase present in the brain.
A number of reports have shown the importance of uridine kinase (EC 2.7.1.48) in cancer chemotherapy with uridine or cytidine analogues, and it was shown that the development of resistance towards these anti-metabolites is associated with changes in some characteristics of the enzyme (Skold, 1963; Vesely et al., 1971; Keefer et al., 1974) . Uridine kinase exists in different forms in Novikoff hepatoma (Krystal & Scholefield, 1973; Keefer et al., 1975) , in foetal liver (Krystal & Webb, 1971 ; Roux & Tuilie, 1974) and rat kidney (Vesely & Smrt, 1977) .
We undertook a study of the heterogeneity of rat uridine kinase, using polyacrylamide-gel electrophoresis and electrofocusing. The present paper describes the different patterns obtained with the enzyme from foetal, adult and tumoral tissues.
Materials and Methods
The enzyme was extracted from the liver, cerebrum, kidney and spleen of male Sherman rats aged 4 months. Foetal (Frayssinet & Lafarge, 1966) .
The enzyme extracts were prepared by the method described by Fulchignoni-Lataud et al. (1976) . The stock enzyme was dissolved in a minimal volume of 20mM-potassium phosphate (pH 7.4), containing 1 mM-dithiothreitol (Sigma), and remained stable for several months at -200C.
Uridine kinase activity was measured as described by Skold (1960) in 0.2 ml of medium containing 0.64mM-[2-14Cluridine (CEA, Saclay, France) (0.O5,Ci per test), 30mM-ATP (Sigma) and 20mM-MgSO4 (Merck). The radioactivity in the uridine nucleotides formed (UMP, UDP and UTP) was measured by the filter-disc method (Ives et al., 1969) in a Nuclear-Chicago liquid-scintillation counter mark I. Protein was measured by the method of Lowry et al. (1951) .
Polyacrylamide-gel electrophoresis was performed in glass tubes (5 mm diam. x 100mm long) by using a multiphasic buffer system (Tris/ HCI/Tris/glycine) as described by . The size of the gels was 5mmx80mm. The polyacrylamide (Eastman/ Kodak) gels were prepared with 1.5 M-Tris/HCI buffer (pH 9), stored overnight at 40C and then prerun at 40C for 60min at 2.5 mA/gel. Tris/HCl buffer (pH 9), containing 1 mM-dithiothreitol and 0.3mM-ATP, was used in the cathode compartment.
The enzyme samples (100-200,ug of protein) were applied to the gel in 200,u1 of 20mM-potassium phosphate buffer (pH 7.4) containing sucrose (150 g/litre) and Bromophenol Blue (0.025 g/litre). Electrophoresis was carried out for 2 h with a constant current of 2.5 mA/gel. The gel was sliced into 2 mm discs, each disc being immediately immersed in 250,1 of standard reaction mixture for the assay of uridine kinase activity.
Isoelectric focusing was performed in polyacrylamide gels (5mm diam. x 80mm long; 38.8g of acrylamide/litre plus 1.2 g of methylenebisacrylamide/litre) containing glycerol (150ml/litre) and carrier ampholytes in pH range 5.4-7.5 obtained by mixing LKB Ampholine pH 4-6 (8 ml/litre), pH 5-7 (32 ml/litre) and pH 7-9 (8 ml/litre). The cathode tank contained 0.1 M-NaOH and the anode tank 0.02M-H3PO4. After the gels had been prefocused for 1h, the samples (100-200#ug of protein) were applied in 200,u1 of 20mM-potassium phosphate buffer containing glycerol (150 ml/litre). Electrofocusing was performed at 40C for 2h to a final potential of 400V. Gels were sliced into 2mm discs, and each disc was immediately assayed for uridine kinase activity as described above. A duplicate gel was sliced and each disc was eluted with 1 ml of 0.5 M-NaCl overnight to determine the pH gradient.
Results and Discussion
The results of electrophoresis of uridine kinase extracted from foetal rat liver are shown in Fig. 1 and demonstrate four electrophoretically distinct forms of the enzyme, designated types I-IV in decreasing order of mobility towards the anode. In previous work we found that the enzyme from foetal liver could be separated into two active fractions by DEAE-cellulose chromatography (FulchignoniLataud et al., 1976) . One of these forms was specific to the foetal tissue, the second being common to adult and foetal liver. These two fractions were submitted separately to polyacrylamide-gel electrophoresis. The foetal-specific form of the enzyme gave only one large fast-migrating peak, corresponding to the type-I enzyme. The second uridine kinaseactive fraction was resolved into three peaks with Rm (i.e. mobility relative to that of the tracking dye) values identical with those found for the slowmigrating peaks of the crude extracts (i.e. types II, III and IV).
The results of isoelectric focusing the two active fractions separated by DEAE-cellulose chromatography are presented in Fig. 2 . The fraction common to adult and foetal liver was again separated into three distinct peaks of activity, focusing at pH 7.66, 6.78 and 6.52 within a pH gradient of 5.4-7.5. On the other hand, the large fast-migrating peak I, which represented the foetal form of the enzyme, was divided into two bands, focusing at pH 6.72 and 6.50.
The relationship between mobility, gel concentration, molecular size and net charge has been well established by . When relative mobility is measured in each of three or more gel concentrations, a linear Ferguson (1964) plot (log Rm versus total acrylamide concentration) can be constructed. The slope of this curve is a measure of the molecular size, and the anti-log of , fraction common to foetal and adult liver. Uridine kinase activity is expressed as in Fig. 1 . RAPID PAPERS the y intercept is a measure of the free electrophoretic mobility and therefore of the net charge. The Ferguson plots of the results obtained with polyacrylamide gels at six different concentrations from 75 to 35 g/litre are shown in Fig. 3 . It is evident that form I is the least charged and the lightest molecule. The three other electrophoretically distinct molecules are more strongly charged and they migrate slowly in the gel because of their high molecular weights. Analysis of the data shows that the slopes for lines I, II and IV are simple multiples (x 1, x 2 and x 4 respectively). Moreover, all three lines extrapolate to a common point at a low gel concentration (approx. 15 g/litre). According to the work of Hedrick & Smith (1968) , forms II and IV of uridine kinase are probably dimers and tetramers respectively of form I.
As shown above, type I can be separated from types II and IV by DEAE-cellulose chromatography, therefore polymerization is not consequent on polyacrylamide-gel electrophoresis. Forms III and IV are of similar size but different net charge, and consequently forms I and III are proteins of different molecular size and charge.
Uridine kinase extracts from various adult rat tissues were submitted to analytical polyacrylamide-gel electrophoresis as described above. Table  1 summarizes the results obtained with kidney, spleen, liver and cerebrum. Type-I uridine kinase was not found in any of the adult tissue extracts investigated. The kidney was the sole adult organ to contain all of the other three forms (II, III and IV). The spleen and liver both contained type-III and type-IV uridine kinase, although type IV was scarce and sometimes lacking altogether in the liver. The cerebrum exhibited a single large band of activity, identified by its Rm as type IV. Because of the different patterns obtained for foetal and adult liver, we investigated the electrophoretic behaviour of liver extracts taken at different stages of development (Table 2) . Type I was present in the liver until the 20th day of gestation, the intensity of the peak decreasing rapidly till birth. This form was absent from the liver extracts taken from newborn rats killed within the first hours of postnatal life. Type II was present up to the third or fourth postnatal day. By day 5 the mature pattern was seen. Uridine kinase extracts from a rapidly growing undifferentiated hepatoma had the same pattern as obtained with foetal liver (Table 2 ). Assuming that the presence of type-I uridine kinase is related to rapidly dividing cells, we studied the fast-growing period specific to spleen (day 5 after birth) and to cerebrum (day 15 of gestation). The electrophoretic pattern obtained for both was similar to that obtained for foetal liver, where type I is present. Regenerating liver can also be used as a model for actively dividing liver cells, but we did not find type-I uridine kinase after partial hepatectomy. The presence of this form of uridine kinase in the foetal liver and its disappearance on the 20th day of gestation could be related to the decrease in the haemopoietic activity in the latter organ at this stage of development. The results reported above show that type-I uridine kinase resolved by polyacrylamide-gel electrophoresis is the foetal-specific form described previously (Roux & Tuilie, 1974; Fulchignoni-Lataud et al., 1976) and could be related to the embryonic low-molecular-weight form isolated by other authors (Krystal & Webb, 1971; Krystal & Scholefield, 1973; Keefer et al., 1975) . The presence of three distinct enzyme forms in the kidney is confirmed by the findings of Vesely & Smrt (1977) . As yet, the term isoenzyme cannot be used for these four species of uridine kinase. However, types I, II and IV are related by multiples of their molecular weight, the molecular weights of types II and IV being respectively 2 and 4 times that of type I. On consideration of such physical factors as molecular weight and charge, type III is distinctly different from the other three forms, and hence a tentative explanation could be that it is an isomer of type I. The technique described here is a useful tool for the analysis of uridine kinase activity in different tissues and could be applied, in our opinion, to the study of variations in the enzyme in different pathological conditions.
